Hims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced? MarketBeat analyst Gabriel Osorio-Mazilli breaks down why this telehealth stock is gaining massive momentum, what's driving its growth, and whether there's still room to buy.
Looking for more explosive growth stocks with a strong future ahead? Check out our recent video on Palantir: https://youtu.be/eAToAA2j8nc
📊 Get Our FREE Report on High Short Interest Stocks
👉 hhttps://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=shortinterest&RegistrationCode=YouTube-shortinterest&SplitTestCode=0
📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks.
✨ Get MarketBeat All Access FREE for 30 Days:
👉 https://www.marketbeat.com/subscribe/all-access/?utm_source=YouTube&RegistrationCode=YouTube
#StocksToBuy #HIMS #HealthcareStocks #InvestingVideos #StockMarket #InvestingTips #Telehealth #MarketBeat #HIMSandHERS
